407 related articles for article (PubMed ID: 23399556)
1. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; McWilliams RR; Chari ST
Am J Gastroenterol; 2013 Apr; 108(4):510-9; quiz 520. PubMed ID: 23399556
[TBL] [Abstract][Full Text] [Related]
2. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Nie SP; Chen H; Zhuang MQ; Lu M
Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538
[TBL] [Abstract][Full Text] [Related]
3. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh H; Singh PP; Murad MH; Limburg PJ
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2258-68. PubMed ID: 24042261
[TBL] [Abstract][Full Text] [Related]
5. The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies.
Hidayat K; Du X; Wu MJ; Shi BM
Obes Rev; 2019 Oct; 20(10):1494-1503. PubMed ID: 31250977
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis.
Zhao Z; He X; Sun Y
Front Pharmacol; 2023; 14():1193610. PubMed ID: 37497113
[No Abstract] [Full Text] [Related]
7. Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies.
Wu L; Zhu J; Prokop LJ; Murad MH
Sci Rep; 2015 Jun; 5():10147. PubMed ID: 26076034
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of thiazolidinediones and fractures in older adults with diabetes.
Solomon DH; Cadarette SM; Choudhry NK; Canning C; Levin R; Stürmer T
J Clin Endocrinol Metab; 2009 Aug; 94(8):2792-8. PubMed ID: 19470635
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis.
Liu Y; Jin PP; Sun XC; Hu TT
Saudi J Gastroenterol; 2018; 24(2):75-81. PubMed ID: 29637913
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.
Chen Y; Du L; Li L; Ma J; Geng X; Yao X; Liu G; Sun X
J Diabetes; 2017 May; 9(5):482-494. PubMed ID: 27273872
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
Tian J; Liang Y; Qu P
Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
[TBL] [Abstract][Full Text] [Related]
13. The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies.
Varas-Lorenzo C; Margulis AV; Pladevall M; Riera-Guardia N; Calingaert B; Hazell L; Romio S; Perez-Gutthann S
BMC Cardiovasc Disord; 2014 Sep; 14():129. PubMed ID: 25260374
[TBL] [Abstract][Full Text] [Related]
14. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Am J Gastroenterol; 2012 Apr; 107(4):620-6. PubMed ID: 22290402
[TBL] [Abstract][Full Text] [Related]
15. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis.
Kowall B; Rathmann W; Kostev K
Diabetes Care; 2015 Jan; 38(1):59-65. PubMed ID: 25336750
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.
Hernandez AV; Usmani A; Rajamanickam A; Moheet A
Am J Cardiovasc Drugs; 2011; 11(2):115-28. PubMed ID: 21294599
[TBL] [Abstract][Full Text] [Related]
17. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
18. Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis.
Wu Y; Liu HB; Shi XF; Song Y
PLoS One; 2014; 9(6):e99577. PubMed ID: 24924771
[TBL] [Abstract][Full Text] [Related]
19. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes.
Prentice JC; Conlin PR; Gellad WF; Edelman D; Lee TA; Pizer SD
Value Health; 2014 Dec; 17(8):854-62. PubMed ID: 25498781
[TBL] [Abstract][Full Text] [Related]
20. The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea.
Lee DY; Yu JH; Park S; Han K; Kim NH; Yoo HJ; Choi KM; Baik SH; Kim NH; Seo JA
Sci Rep; 2018 Jun; 8(1):9719. PubMed ID: 29946194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]